Performance of six diagnostic tests to screen for Chagas disease in blood banks and prevalence of Trypanosoma cruzi infection among donors with inconclusive serology screening based on the analysis of epidemiological variables

Revista Brasileira de Hematologia e Hemoterapia

Volumn 34, Issue 4, 2012, Pages 292-297

  Pereira, Gilberto de Araujo ^a   Louzada Neto, Francisco ^b   Barbosa, Valdirene de Fátima ^a   Ferreira Silva, Márcia Maria ^a   de Moraes Souza, Helio ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Blood donors; Chagas disease; Epidemiologic factors; Sensitivity and specificity

Indexed keywords

EID: 84866402496     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.5581/1516-8484.20120074     Document Type: Article

References (30)

1. WHO 2010. First WHO report on neglected tropical diseases: Working to overcome the global impact of neglected tropical diseases (WHO/ HTM/NTD/2010.1) 2010 [cited 2012 March 20]; Available from: http://whqlibdoc.who.int/publications/2010/9789241564090_eng.pdf
2. Organización Panamericana de la Salud. Estimación cuantitativa de la enfermedad de Chagas en las Americas. Geneva, Switzerland: OPAS; 2006. 28p.
3. Souza HM. Mecanismos alternativos de transmissäo parenteral da Doença de Chagas. Rev Méd Minas Gerais. 1993; 3(2):93-95
4. Schmunis GA. Tripanosomíase Americana: seu impacto nas Américas e perspectivas de eliminação. In: Dias JC, Coura JR, organizadores. Clínica e terapêutica da doença de Chagas: uma abordagem prática para o clínico geral Rio de Janeiro: Fiocruz; 1997. p 11-24.
5. Dias JC. Elimination of Chagas disease transmission: perspectives Mem Inst Oswaldo Cruz. 2009;104(Suppl 1):41-45.
6. Schmunis GA. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz. 2007; 102(Suppl 1):75-85.
7. Salles NA, Sabino EC, Cliquet MG, Eluf-Neto J, Mayer A, Almeida-Neto C, et al. Risk of exposure to Chagas disease among seroreactive Brazilian blood donors. Transfusion. 1996;36(11-12):969-973.
8. Melo AS, Lorena VM, Moraes AB, Pinto MB, Leão SC, Soares AK, et al. The prevalence of chagasic infection among blood donors in the state of Pernambuco, Brazil. Rev Bras Hematol Hemoter. 2009;31(2):69-73.
9. Reesink HW. European strategies against the parasite transfusion risk. Transfus Clin Biol. 2005;12(1):1-4.
10. Furuchó, CR, Umezawa, ES, Almeida, I, Freitas, VL, Bezerra, R, Nunes EV, et al. Inconclusive results in conventional serological screening for Chagas' disease in blood banks: evaluation of cellular and humoral response. Trop Med Int Health. 2008;13(12):1527-1533.
11. Ferreira-Silva MM, Pereira GA, Lages-Silva E, Moraes-Souza H. Socioepidemiological screening of serologically ineligible blood donors due to Chagas disease for the definition of inconclusive cases. Mem Inst Oswaldo Cruz. 2010;105(6):800-805.
12. Meira WS, Galvão LM, Gontijo ED, Machado-Coelho GL, Norris KA, Chiari E. Trypanosoma cruzi complement regulatory protein: a novel antigen for use in enzyme-linked immunosorbent assay for diagnosis of Chagas disease. J Clin Microbiol. 2002;40(10):3735-3740.
13. Umezawa ES, Bastos SF, Coura JR, Levin MJ, Gonzalez A, Rangel-Aldao R, et al. An improved serodiagnostic test for Chagas disease employing a mixture of Trypanosoma cruzi recombinant antigens. Transfusion. 2003;43(1):91-97.
14. Umezawa ES, Luquetti AO, Levitus G, Ponce C, Henriquez D, Revollo S, et al. Serodiagnosis of chronic and acute Chagas disease with Trypanosoma cruzi recombinant proteins: results of a collaborative study in six Latin American countries. J Clin Microbiol. 2004;42(1):449-452.
15. Cheng KY, Chang CD, Salbilla VA, Kirchhoff LV, Leiby DA, Schohetman, Chat DO. Immunoblot assay using recombinant antigens as a supplemental test to confirm the presence of antibodies to Trypanosoma cruzi. Clin Vaccine Immunol. 2007;14(4):355-361.
16. Hadgu A, Qu Y. A Biomedical application of latent class models with random effects. Appl Stat. 1998;47(4):603-616.
17. Martinez EZ, Louzada-Neto F, Achcar JA, Syrjänen KJ, Derchain SF, Gontijo RC, et al. Bayesian Estimation of performance measures of screening tests in the presence of covariates: an absence of a gold standard. Braz J Probab Stat. 2009;23(1):68-81.
18. Hui SL, Walter SD. Estimating the error rates of diagnostic tests. Biometrics. 1980;36(1):167-171.
19. Langhi Junior DM, Bordin JO, Castelo A, Walter SD, Moraes-Souza H, Stumpf RJ. The application of latent class analysis for diagnostic test validation of chronic trypanosoma cruzi infection in blood donors. Braz J Infect Dis. 2002;6(40):181-187.
20. Flores-Chávez M, Cruz I, Rodríguez M, Nieto J, Franco E, Gárate T, et al. Comparación de técnicas serológicas convencionales y no convencionales para El diagnóstico de la enfermedad de Chagas importada en España. Enferm Infecc Microbiol Clin 2010;28(5):284-293.Spanish.
21. Praast G, Herzogenrath J, Bernhardt S, Christ H, Sickinger E. Evaluation of the Abbott ARCHITECT Chagas prototype assay. Diagn Microbiol Infect Dis. 2011;69(1):74-81.
22. Gadelha AA, Verçosa AF, Lorena VM, Nakazawa M, Carvalho AB, Souza WV, et al. Chagas disease diagnosis: comparative analysis of recombinant ELISA with conventional ELISA and the haemagglutination test. Vox Sang. 2003;85(3):165-170.
23. Pirard M, Iihoshi N, Boelaert M, Basanta P, López F, der Stuyft P. The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion. 2005;45(4):554-561.
24. Lunardelli A, Borges FP, Mello KF, Zeferino AS. Soroprevalência da doença de Chagas em candidatos a doadores de sangue. Rev Bras Anal Clin. 2007;39(2):139-141.
25. Brasil PE, Castro L, Hasslocher-Moreno Am, Sangenis L, Braga JU. Elisa versus PCR for diagnosis of chronic Chagas disease: Systematic review and meta-analysis. BMC Infect Dis. 2010;10:337-353.
26. o 153, de 14 de junho de 2004. Publicada no Diário Oficial da união de 24 de junho de 2004. [citado 2001 Out 11]. Available from: http://e-legis.anvisa.gov.br/leisref/public/showAct.php?id=11662.
27. o 57, de 17 de outubro de 2010. Publicada no Diário Oficial da União em 16 de dezembro de 2010. [citado 2011 Out 11]. Available from: http://portal.anvisa.gov.br/.
28. Leiby DA, Herron RM Jr, Garratty G, Herwaldt BL. Trypanosoma cruzi parasitemia in: US Blood donors with serologic evidence of infection. J Infect Dis. 2008;198(4):609-613
29. Sabino EC, Salles NA, Sarr M, Barreto AM, Oikawa M, Oliveira CD, Leao SC, Carneiro-Proietti AB, Custer B, Busch MP; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component. Enhanced classification of Chagas serologic results and epidemiologic characteristics of seropositive donors at three large blood centers in Brazil. Transfusion. 2010;50(12):2628-2637.
30. Arango HG. Bioestatística: teórica e computacional. 2nd ed. Rio de Janeiro: Guanabara Koogan; 2005.